Prolonged treatment of an immunocompromised child with oseltamivir and zanamivir for A(H1N1)pdm09 virus infection led to the emergence of viruses carrying H275Y and/or E119G in the neuraminidase. When phenotypically evaluated by neuraminidase inhibition, the dual H275Y-E119G substitution caused highly reduced inhibition by four neuraminidase inhibitors including oseltamivir, zanamivir, peramivir and laninamivir
We report characteristics of oseltamivir-resistant influenza A(H1N1)pdm09 viruses and patients infec...
Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral...
Emergence of multidrug resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child...
Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) has remained...
Background: Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) ...
Neuraminidase (NA) inhibitors (NAIs), including oseltamivir and zanamivir, play an important therape...
An influenza A(H1N1)pdm09 infection was diagnosed in a hematopoietic stem cell transplant recipient ...
BACKGROUND: Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) ...
To identify mutations that can arise in highly pathogenic A(H5N1) viruses under neuraminidase inhibi...
We report the emergence of an influenza virus A/H3N2-E119V neuraminidase variant from an elderly pat...
The clinical use of the neuraminidase inhibitor (NAI) oseltamivir is associated with the emergence o...
Resistance of influenza A viruses to neuraminidase inhibitors can arise throughmutations in the neur...
Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral...
In the treatment of influenza, Neuraminidase inhibitors (NAIs) (Oseltamivir and Zanamivir) play a ma...
During May 2009–April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in M...
We report characteristics of oseltamivir-resistant influenza A(H1N1)pdm09 viruses and patients infec...
Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral...
Emergence of multidrug resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child...
Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) has remained...
Background: Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) ...
Neuraminidase (NA) inhibitors (NAIs), including oseltamivir and zanamivir, play an important therape...
An influenza A(H1N1)pdm09 infection was diagnosed in a hematopoietic stem cell transplant recipient ...
BACKGROUND: Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) ...
To identify mutations that can arise in highly pathogenic A(H5N1) viruses under neuraminidase inhibi...
We report the emergence of an influenza virus A/H3N2-E119V neuraminidase variant from an elderly pat...
The clinical use of the neuraminidase inhibitor (NAI) oseltamivir is associated with the emergence o...
Resistance of influenza A viruses to neuraminidase inhibitors can arise throughmutations in the neur...
Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral...
In the treatment of influenza, Neuraminidase inhibitors (NAIs) (Oseltamivir and Zanamivir) play a ma...
During May 2009–April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in M...
We report characteristics of oseltamivir-resistant influenza A(H1N1)pdm09 viruses and patients infec...
Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral...
Emergence of multidrug resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child...